about
A revised nomenclature for transcribed human endogenous retroviral lociTumour microvesicles contain retrotransposon elements and amplified oncogene sequencesAnalysis of transcribed human endogenous retrovirus W env loci clarifies the origin of multiple sclerosis-associated retrovirus env sequencesExpression of evolutionarily novel genes in tumorsEndogenous retroviruses and the development of cancerAre human endogenous retroviruses pathogenic? An approach to testing the hypothesisIdentification of BC005512 as a DNA damage responsive murine endogenous retrovirus of GLN family involved in cell growth regulationDetecting endogenous retrovirus-driven tissue-specific gene transcriptionA novel endogenous betaretrovirus in the common vampire bat (Desmodus rotundus) suggests multiple independent infection and cross-species transmission eventsUnfixed endogenous retroviral insertions in the human populationA reverse transcriptase-dependent mechanism is essential for murine preimplantation developmentVariant splicing and influence of ionizing radiation on human endogenous retrovirus K (HERV-K) transcripts in cancer cell linesA novel endogenous betaretrovirus group characterized from polar bears (Ursus maritimus) and giant pandas (Ailuropoda melanoleuca)Evolutionary medicine: its scope, interest and potentialImproved integration time estimation of endogenous retroviruses with phylogenetic dataHuman endogenous retrovirus HERV-K(HML-2) encodes a stable signal peptide with biological properties distinct from RecVlincRNAs controlled by retroviral elements are a hallmark of pluripotency and cancer.View and review on viral oncology research.Elevated HERV-K mRNA expression in PBMC is associated with a prostate cancer diagnosis particularly in older men and smokersAn N-terminally truncated envelope protein encoded by a human endogenous retrovirus W locus on chromosome Xq22.3.The transmembrane protein of the human endogenous retrovirus--K (HERV-K) modulates cytokine release and gene expressionHERV-E-mediated modulation of PLA2G4A transcription in urothelial carcinoma.HERV-K(HML-2), a seemingly silent subtenant - but still waters run deep.Involvement of endogenous retroviruses in prion diseases.The HERV-K human endogenous retrovirus envelope protein antagonizes Tetherin antiviral activityCancer gene discovery in mouse and man.copy number variation analysis in familial BRCA1/2-negative Finnish breast and ovarian cancer.Expression of human endogenous retrovirus-w including syncytin-1 in cutaneous T-cell lymphomaExpression of dual-specificity phosphatase 5 pseudogene 1 (DUSP5P1) in tumor cellsHERV-K(HML-2) rec and np9 transcripts not restricted to disease but present in many normal human tissues.Bovine spongiform encephalopathy infection alters endogenous retrovirus expression in distinct brain regions of cynomolgus macaques (Macaca fascicularis)Inactivation of the von Hippel-Lindau tumor suppressor leads to selective expression of a human endogenous retrovirus in kidney cancer.Differential expression of HERV-K (HML-2) proviruses in cells and virions of the teratocarcinoma cell line Tera-1.Global methylation in exposure biology and translational medical science.Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.Polymorphic integrations of an endogenous gammaretrovirus in the mule deer genome.High Expression of Endogenous Retroviral Envelope Gene in the Equine Fetal Part of the Placenta.Np9, a cellular protein of retroviral ancestry restricted to human, chimpanzee and gorilla, binds and regulates ubiquitin ligase MDM2.HERV-K-specific T cells eliminate diverse HIV-1/2 and SIV primary isolates.Endogenous retrovirus-K promoter: a landing strip for inflammatory transcription factors?
P2860
Q21030654-D2834523-BC6F-4F8F-A836-CB174B258630Q21147057-B252FB12-5C3D-44C6-9A06-C4792EA708A8Q21245052-4B36873D-4C73-407F-8525-2D724B395933Q26738894-7FE95379-DCCC-4AE5-891E-A1CE465901D4Q26852000-273F7D0F-C99F-48D5-B824-3D9D0B0AC615Q27011469-9706CA39-326F-473D-90A5-41E45F60D2C8Q28482277-9F0C2039-C833-40CD-890B-BAB3D9E8DCFFQ28648065-4433EA22-A867-4378-A771-BAB70CEF6F62Q28649469-65A50E06-F6FF-4951-ABB8-C02500801185Q28654487-F563052F-4AC0-49DB-92C2-4F09C10BF2C9Q28659108-DD0C9E68-CDDC-485A-B322-8CC2BBF5792FQ28672938-B4AB2739-123D-4E17-A892-2E683BDC9DE0Q28680704-078B645F-27A9-42C8-9569-4E71454A2AE2Q28715053-F4BA57CA-1E6E-423D-A1D9-515A302AA323Q28742233-E6AE488C-C107-4B06-A29D-D595ED2267C0Q28755322-77B0D7B7-10B8-4BF8-9218-95BD015CEF8BQ33742588-13B005AD-2931-4E76-B268-273A7D46CE0BQ33894872-1835D6CD-85A1-437E-858B-108AC01057C6Q34096832-19EB0991-E4F9-4319-9812-635369B7386FQ34114493-7C8B2173-5642-4723-BA83-78A7642B88DBQ34364497-2BE1E5B8-F44A-4AB9-B72A-22D3BB9CAE8EQ34474418-1D730692-DED4-4B35-8A60-DB96AF2163C5Q34511101-68F4F8FB-2142-4A82-A438-933E9C8B6523Q34533430-52B9E12F-81BA-49FE-B2C6-3C6C5207E7CBQ34594080-6A5FD16A-ECD7-4CF8-A99F-5C878FB92C3CQ34962407-8C3D6E82-A575-48D9-9BE9-E57FEBD435D3Q34964524-4D99EBD0-798F-4D84-A570-CF3E891BF3DBQ35009341-EC023159-F2C0-41ED-B5B2-6C2427BAB22AQ35126260-571F13F5-1323-4B5B-880A-A0E159EFC011Q35154110-04CAEC32-311B-4CDA-B3EA-124BCB191EBCQ35155029-DD02C5DE-D1C0-45A9-AA72-0CBCDFAF0F40Q35179504-D278AB91-0C9A-46FD-9042-164CE524EA00Q35232788-129D596E-A947-474F-A61E-F81F71DD917BQ35579907-4A388CE4-EE78-4CDB-9898-3C8EAD11C516Q35586619-C9C4FB26-ED0F-46FC-8F18-12428C5E4A72Q35826046-73E0E4C2-40E6-460E-B7CA-FAC4DEB5EB10Q36016947-0DF8049F-3989-4062-84D4-50EBA0FF9330Q36186500-5432DBA9-8E09-401F-A5F3-102DD903B5CDQ36498080-3AC4F009-A3F1-4FF7-93B3-5ED54E8EAADBQ36687211-7D8FA680-9F0D-4876-9193-8C9047DDFF03
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Endogenous retroviruses and cancer.
@en
Endogenous retroviruses and cancer.
@nl
type
label
Endogenous retroviruses and cancer.
@en
Endogenous retroviruses and cancer.
@nl
prefLabel
Endogenous retroviruses and cancer.
@en
Endogenous retroviruses and cancer.
@nl
P2093
P1476
Endogenous retroviruses and cancer.
@en
P2093
K Ruprecht
N Mueller-Lantzsch
P2888
P304
P356
10.1007/S00018-008-8496-1
P577
2008-11-01T00:00:00Z